Published in Exp Ther Med on April 29, 2014
Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surg Today (2016) 0.82
Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis. World J Gastroenterol (2015) 0.77
A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med (2016) 0.75
Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study. Chin J Cancer Res (2016) 0.75
Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide. Transl Oncol (2017) 0.75
The clinicopathological and prognostic role of thrombocytosis in patients with cancer: A meta-analysis. Oncol Lett (2017) 0.75
Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review. Oncotarget (2017) 0.75
Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma. Int J Clin Oncol (2017) 0.75
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood (2004) 3.13
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer (2003) 2.20
Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med (1996) 2.20
Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int (2000) 2.04
Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol (2002) 2.03
Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol (1997) 1.71
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood (2000) 1.70
Molecular aspects of myeloproliferative neoplasms. Int J Hematol (2010) 1.67
The thrombophilic state in cancer patients. Acta Haematol (2001) 1.27
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. Anticancer Drugs (2005) 1.24
Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration (2004) 1.15
Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. Int J Clin Exp Pathol (2013) 1.13
The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet (2008) 1.02
Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Res (2013) 1.01
Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol (2010) 0.99
Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncol Lett (2012) 0.94
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol (2007) 0.89
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders. Platelets (2007) 0.88
Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai (2007) 0.87
Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients. Monaldi Arch Chest Dis (2004) 0.86
Significance of platelet counts in patients who underwent surgical treatment for lung metastasis. Int Surg (2007) 0.85
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp Cell Res (1993) 0.85
Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer. Gen Thorac Cardiovasc Surg (2010) 0.84
Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res (2003) 0.82
Significance of platelet count in esophageal carcinomas. Saudi J Gastroenterol (2011) 0.81
Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci (2011) 0.78